Generation of multinucleated giant cells by culture of monocyte-derived macrophages with IL-4

被引:29
作者
Dugast, C [1 ]
Gaudin, A [1 ]
Toujas, L [1 ]
机构
[1] CTR REG LUTTE CANC,DEPT BIOL,F-35062 RENNES,FRANCE
关键词
human; cytokines; CD antigens; phagocytosis;
D O I
10.1002/jlb.61.4.517
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Culturing human monocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) has been reported to provoke the formation of multinucleated giant cells (GCs). In the present work, GCs were generated in a two-step procedure in which macrophages were first differentiated from monocytes before being fused into GCs. The two cytokines used acted sequentially, GM-CSF was required for monocyte differentiation and IL-4 for macrophage fusion. Macrophages were purified from cultures of blood mononuclear cells maintained for 7 days in plastic bags. When seeded in conventional plastic-ware in the presence of IL-4, these macrophages showed an increased motility, spread in thin cytoplasmic lamellas, regrouped in clusters, and within 1-3 weeks, differentiated into GCs. Multinucleated cells also appeared in IL-4-untreated macrophage cultures but the number of nuclei did not exceed 2 or 3, compared with more than 30 in the presence of IL-4. Scanning electron microscopy of GCs showed highly developed pseudopods. GCs reacted with anti-CD11b, -CD54, -CD68, -HLA-ABC, and -HLA-DR monoclonal antibodies and AMH-152 but were CD14- and CD64-negative. Both untreated and IL-4-treated macrophages conserved pinocytic and phagocytic activity. Thus, IL-4 induced a differentiation process in which macrophages lost markers like CD14 and CD64, acquired an enhanced membrane motility, and fused in multinucleated GCs.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 24 条
[1]  
ABE E, 1991, J IMMUNOL, V147, P1810
[2]  
ANDREESEN R, 1990, CANCER RES, V50, P7450
[3]   Adhesion molecule expression and response to chemotactic agents of human monocyte-derived macrophages [J].
Audran, R ;
Lesimple, T ;
Delamaire, M ;
Picot, C ;
VanDamme, J ;
Toujas, L .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) :155-160
[4]  
AUDRAN R, 1995, LEUKOCYTE TYPING, V5, P1052
[5]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[6]  
FAIS S, 1994, LAB INVEST, V71, P737
[7]   CYTOKINE CONTROL OF PERIPHERAL-BLOOD CD23 EXPRESSION AND SCD23 RELEASE - DIFFERENTIAL REGULATION BY IL-2 AND IL-4 [J].
FISCHER, A ;
PFEIL, T ;
KONIG, W .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 92 (04) :334-342
[8]   INHIBITION OF HUMAN MACROPHAGE COLONY FORMATION BY INTERLEUKIN-4 [J].
JANSEN, JH ;
WIENTJENS, GJHM ;
FIBBE, WE ;
WILLEMZE, R ;
KLUINNELEMANS, HC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :577-582
[9]  
KATIRA A, 1995, CD40 WORKSH PAN REP, V5, P547
[10]   INTERLEUKIN-4 AND HUMAN-IMMUNODEFICIENCY-VIRUS STIMULATE LFA-1-ICAM-MEDIATED AGGREGATION OF MONOCYTES AND SUBSEQUENT GIANT-CELL FORMATION [J].
KAZAZI, F ;
CHANG, J ;
LOPEZ, A ;
VADAS, M ;
CUNNINGHAM, AL .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :2795-2802